Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DX-8951f in Advanced or Recurrent Cervical Cancer
NCT00004866Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2000
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exatecan in Cervical Cancer (CC), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2000; status: completed.
02
Drugs
exatecan
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00004866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004866.